mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.9 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |